Developer docs
API playgroundTry for free, no card

Search company profiles

Cancer Treatment Centers of America

Full company profile

uuid0007m15

Namestring
Cancer Treatment Centers of America
Legal namestring
Cancer Treatment Centers of America
Company typeenum
Private
Founded yearint
1988
Descriptiontext

Cancer Treatment Centers of America, now operating under the City of Hope brand following a merger, is a private, for-profit national oncology care platform headquartered operationally at Duarte, California (with corporate registration tied to Boca Raton, Florida). The company operates five inpatient hospital campuses in Atlanta, Chicago, Duarte, Orange County, and Phoenix, supported by seven outpatient care centers across Arizona, Illinois, and Georgia. It was founded in 1988 and employs 5,001–10,000 people. City of Hope brings a 100+ year research legacy and is a founding member of the National Comprehensive Cancer Network (NCCN).

The platform delivers the full oncology care continuum across 100+ cancer types through dedicated disease-specific centers (Breast Cancer Center, GI Cancer Center, Lung Cancer Center) and treatment modules including chemotherapy, radiation therapy (external beam including IMRT/IGRT/TomoTherapy/proton therapy/SRS/SBRT, brachytherapy, systemic), surgical oncology (open, laparoscopic, robotic, cryosurgery), immunotherapy (checkpoint inhibitors, CAR T-cell, vaccines, cytokines), precision medicine, and theranostics (Pluvicto, radioactive iodine). Diagnostic capabilities span advanced imaging, genetic and genomic testing (BRCA1/2, MammaPrint, Oncotype DX), and laboratory services. Supportive care (nutritional, naturopathic, behavioral health, pain management, spiritual, survivorship) and the ASURE enhanced surgical recovery program provide whole-person wraparound services.

Revenue is generated through professional services for inpatient and outpatient cancer care, billed primarily through commercial insurance and most Medicare plans; pricing is not publicly disclosed and varies by plan and treatment regimen. The go-to-market motion is direct-to-consumer: patients self-refer via a 24/7 phone line (888-552-6760), website, or live chat, supported by insurance verification, physician referrals, telehealth, and an international patient services channel. Customers are individual cancer patients segmented by tumor type rather than institutional buyers. Leadership includes CEO Pat Basu, Founder/Chairman Richard J Stephenson, CFO Douglas Costa, CIO Jennifer Greenman, CMO Julian Schink, COO Pete Govorchin, and CMO Ken Chaplin.

Short descriptiontext

Cancer Treatment Centers of America, now operating as City of Hope, is a private national oncology platform running five hospital campuses and seven outpatient centers across the U.S., delivering comprehensive personalized cancer treatment to individual patients across 100+ cancer types.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
5,001–10,000
akta.pro rankint
HeadquartersBoca Raton, United States
HQ citystring
Boca Raton
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices12 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
cancer treatment services, oncology care, radiation therapy, surgical oncology, precision medicine
Industry4 codes
1Oncology & Cancer Specialty Hospitals
CodeHLAFAHACPrimaryYes
2Ambulatory Oncology Centers (Outpatient Chemo/Radiation)
CodeHLAFABAIPrimaryNo
3Medical Oncology
CodeHLAKAFABPrimaryNo
4Oncology Remote Symptom Monitoring & Care Navigation
CodeHLALAFADPrimaryNo
NAICS code4 codes
  • Specialty (except Psychiatric and Substance Abuse) Hospitals622310
  • Specialty (except Psychiatric and Substance Abuse) Hospitals6223
  • Offices of Physicians62111
  • Ambulatory Health Care Services621
SIC code3 codes
  • Services-Hospitals8060
  • Services-Specialty Outpatient Facilities, Nec8093
  • Services-Offices & Clinics Of Doctors Of Medicine8011
Product category
Oncology Care Services
Social media profiles3 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Patient Care Services
TypeProfessional Services
Description

Revenue generated from comprehensive cancer treatment services including inpatient hospital care, outpatient treatments, diagnostic procedures, surgical services, radiation therapy, chemotherapy, immunotherapy, and supportive care services at hospital campuses and outpatient care centers across multiple U.S. locations

cancercenter.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain
Pricing details1 tier
1Quote-based pricing - patient responsibility varies by insurance plan and treatment regimen
ModelOtherBilling cadenceOther
Notes

Healthcare services are billed through insurance. We accept a variety of insurance policies, most Medicare plans and more. Patients are advised to call for insurance verification to understand their coverage and out-of-pocket costs.

cancercenter.com
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 of 4 records shown
1City of Hope Cancer Treatment Centers
Description

Cancer treatment hospitals and outpatient care centers

cancercenter.com
+3 more records
Core offering1 text field

Cancer Treatment Centers of America (CTCA), now operating under the City of Hope brand, provides comprehensive cancer diagnosis, treatment, and supportive care through a network of specialized cancer hospitals and outpatient care centers. Services span chemotherapy, radiation therapy, surgical oncology, immunotherapy, precision medicine, theranostics, diagnostic imaging, genetic and genomic testing, and supportive care, delivered by multidisciplinary teams under one roof.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Five-year survival rate of 65% for colorectal cancer when detected early (before spread), increasing to 91% when detected before metastasis
+2 more records
Product overview1 text field

City of Hope (formerly Cancer Treatment Centers of America) is a unified cancer care platform comprising specialized cancer hospitals in Atlanta, Chicago, Duarte, Orange County, and Phoenix, supported by multiple Outpatient Care Centers. The organization offers a comprehensive suite of treatment modalities organized around dedicated cancer centers (Breast Cancer Center, GI Cancer Center, Lung Cancer Center) and treatment options including Chemotherapy, Radiation Therapy (external beam, internal, systemic), Surgical Oncology (including robotic surgery and ASURE recovery program), Immunotherapy (checkpoint inhibitors, CAR T-cell, vaccines), Precision Medicine, and Theranostics. Diagnostic capabilities span Genetic/Genomic Testing, Laboratory Tests (MammaPrint, Oncotype DX, CTC tests), and Imaging Services. Supportive Care Services include nutritional support, oncology rehabilitation, pain management, behavioral health, and survivorship support, all delivered through a multidisciplinary team approach under one roof.

Product and service20 records
1City of Hope Cancer Treatment Hospitals
CategoryCancer hospital network
Description

A network of specialized cancer hospitals providing comprehensive inpatient and outpatient cancer care across multiple U.S. locations (Atlanta, Chicago, Duarte, Orange County, Phoenix). Targeted at adult cancer patients requiring multidisciplinary treatment.

2Comprehensive Cancer Treatment Options
CategoryTreatment services
Description

Full spectrum of cancer treatment modalities including chemotherapy, radiation therapy, surgery, immunotherapy, targeted therapy, precision medicine, interventional oncology, and supportive care procedures for adult cancer patients.

3Immunotherapy Program
CategoryTreatment services
Description

Cancer immunotherapy treatments including checkpoint inhibitors (PD-1, CTLA-4), CAR T-cell therapy, cancer vaccines, cytokines, and oncolytic virus therapy for adult cancer patients.

4Chemotherapy Services
CategoryTreatment services
Description

Systemic chemotherapy treatments using alkylating agents, antimetabolites, antitumor antibiotics, topoisomerase inhibitors, mitotic inhibitors, and plant alkaloids, delivered in inpatient and outpatient settings.

5Radiation Therapy
CategoryTreatment services
Description

Radiation oncology services including external beam radiation therapy (IMRT, IGRT, TomoTherapy, proton therapy, SRS, SBRT), internal radiation therapy (brachytherapy), and systemic radiation therapy for adult cancer patients.

6Surgical Oncology
CategoryTreatment services
Description

Surgical cancer treatments including open surgery, minimally invasive laparoscopy, laser surgery, cryosurgery, robotic-assisted surgery, and reconstructive surgery for adult cancer patients.

7Breast Cancer Center
CategorySpecialized cancer center
Description

Dedicated breast cancer treatment center offering diagnosis, staging, and treatment for all breast cancer types including early-stage, triple-negative, and inflammatory breast cancer. Located within each City of Hope hospital campus.

8GI Cancer Center
CategorySpecialized cancer center
Description

Gastrointestinal cancer center specializing in colorectal cancer and other GI malignancies, with nutrition therapy and supportive care services. Located within each City of Hope hospital campus.

9Lung Cancer Center
CategorySpecialized cancer center
Description

Dedicated lung cancer center offering diagnosis, staging, and treatment for NSCLC and SCLC with advanced genomic testing and immunotherapy options. Located within each City of Hope hospital campus.

10Prostate Cancer Treatment
CategoryTreatment services
Description

Prostate cancer treatment including 4D radiation therapy, hormone therapy, immunotherapy, and supportive care focused on quality-of-life maintenance for men diagnosed with prostate cancer.

11Precision Medicine
CategoryTreatment services
Description

Personalized cancer treatment using genetic and tumor marker testing to design targeted therapies based on individual tumor signatures.

12Advanced Surgical Recovery Program (ASURE)
CategorySupport program
Description

Enhanced recovery program combining pre-habilitation, nutrition, pain management with non-narcotic relievers, and physical activity within 24 hours post-surgery, for adult surgical oncology patients.

13Diagnostic Services
CategoryDiagnostic services
Description

Comprehensive cancer diagnostics including biopsy, imaging (CT, MRI, PET/CT, mammography, ultrasound, X-ray, nuclear medicine), laboratory tests, and genetic/genomic testing for adult patients.

14Genetic and Genomic Testing
CategoryDiagnostic services
Description

Advanced genomic testing of tumor DNA and genetic testing for inherited mutations (BRCA1/2) to identify treatment options and cancer risk for adult patients.

15Laboratory Tests
CategoryDiagnostic services
Description

Clinical laboratory testing including CellSearch circulating tumor cell tests, CBC tests, flow cytometry, MammaPrint/BluePrint, Oncotype DX, CEA, and tumor marker tests for adult patients.

16Supportive Care Services
CategorySupport services
Description

Whole-person supportive care including nutritional support, oncology rehabilitation, pain management, spiritual support, behavioral health, naturopathic support, and survivorship support for adult cancer patients and their families.

17Theranostics
CategoryTreatment services
Description

Cancer care combining diagnostics and treatment, including radioactive iodine therapy and Pluvicto for targeted cancer treatment in adult patients.

18Clinical Trials
CategoryResearch services
Description

Access to clinical trials evaluating new drug development, technologies, and innovative treatment approaches for eligible adult cancer patients at City of Hope / CTCA facilities.

19Outpatient Care Centers
CategoryOutpatient facilities
Description

Multiple outpatient care centers in Downtown Chicago, Gilbert, North Phoenix, North Shore, Paces Ferry, Prescott, and Scottsdale providing consultations, follow-up care, and outpatient treatments closer to patients' homes.

20Patient Portal
CategoryPatient services
Description

Online patient portal for accessing medical records, scheduling, and communicating with the care team, available to City of Hope / CTCA patients.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

One of the world's largest dedicated cancer centers, providing comprehensive inpatient and outpatient oncology care, research, and clinical trials. Directly comparable as a specialty oncology hospital network with multidisciplinary, research-driven cancer care.

TypeDirect peer
Description

Premier specialty cancer hospital and research institution with multiple regional outpatient sites. Closely comparable to City of Hope/CTCA as a top-tier, research-driven oncology provider offering surgery, chemotherapy, radiation, immunotherapy, and precision medicine.

TypeBroad incumbent
Description

Large, multispecialty academic health system with a major oncology program across multiple campuses. Comparable as a destination cancer care provider with research, complex care, and multidisciplinary teams, though oncology is part of a broader portfolio.

TypeBroad incumbent
Description

Multispecialty health system with a strong cancer institute and multiple regional hospitals. Comparable as a brand-led, geographically distributed provider of complex oncology care within a broader clinical portfolio.

TypeBroad incumbent
Description

Largest for-profit hospital operator in the U.S., with significant oncology service lines across a national footprint. Comparable as a multi-state, for-profit provider of complex inpatient and outpatient cancer care, though within a diversified hospital portfolio.

TypeBroad incumbent
Description

For-profit hospital system operating specialty and acute care hospitals with oncology service lines. Comparable as a multi-state for-profit provider of complex inpatient and outpatient cancer care within a diversified portfolio.

TypeDirect peer
Description

Specialty cancer hospital and research center with multidisciplinary oncology care and clinical trials. Directly comparable as a research-intensive, specialty cancer provider with similar mission and care model.

TypeDirect peer
Description

NCI-designated Comprehensive Cancer Center offering inpatient and outpatient oncology services, research, and clinical trials. Comparable as a specialty cancer hospital network with multidisciplinary, research-driven cancer care.

TypeDirect peer
Description

Research-driven specialty cancer center with clinical care, bone marrow transplantation, and immunotherapy programs. Directly comparable as a research-intensive oncology specialty provider.

TypeEmerging player
Description

Large network of community-based oncology practices affiliated through McKesson, providing medical oncology, infusion, and radiation services. Comparable as a multi-site oncology delivery platform, though community-focused rather than hospital-based.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile6 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles15 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Cancer Treatment Centers of America

Oncology Care Servicescancercenter.com

Cancer Treatment Centers of America, now operating as City of Hope, is a private national oncology platform running five hospital campuses and seven outpatient centers across the U.S., delivering comprehensive personalized cancer treatment to individual patients across 100+ cancer types.

What Cancer Treatment Centers of America does

Cancer Treatment Centers of America, now operating under the City of Hope brand following a merger, is a private, for-profit national oncology care platform headquartered operationally at Duarte, California (with corporate registration tied to Boca Raton, Florida). The company operates five inpatient hospital campuses in Atlanta, Chicago, Duarte, Orange County, and Phoenix, supported by seven outpatient care centers across Arizona, Illinois, and Georgia. It was founded in 1988 and employs 5,001–10,000 people. City of Hope brings a 100+ year research legacy and is a founding member of the National Comprehensive Cancer Network (NCCN).

The platform delivers the full oncology care continuum across 100+ cancer types through dedicated disease-specific centers (Breast Cancer Center, GI Cancer Center, Lung Cancer Center) and treatment modules including chemotherapy, radiation therapy (external beam including IMRT/IGRT/TomoTherapy/proton therapy/SRS/SBRT, brachytherapy, systemic), surgical oncology (open, laparoscopic, robotic, cryosurgery), immunotherapy (checkpoint inhibitors, CAR T-cell, vaccines, cytokines), precision medicine, and theranostics (Pluvicto, radioactive iodine). Diagnostic capabilities span advanced imaging, genetic and genomic testing (BRCA1/2, MammaPrint, Oncotype DX), and laboratory services. Supportive care (nutritional, naturopathic, behavioral health, pain management, spiritual, survivorship) and the ASURE enhanced surgical recovery program provide whole-person wraparound services.

Revenue is generated through professional services for inpatient and outpatient cancer care, billed primarily through commercial insurance and most Medicare plans; pricing is not publicly disclosed and varies by plan and treatment regimen. The go-to-market motion is direct-to-consumer: patients self-refer via a 24/7 phone line (888-552-6760), website, or live chat, supported by insurance verification, physician referrals, telehealth, and an international patient services channel. Customers are individual cancer patients segmented by tumor type rather than institutional buyers. Leadership includes CEO Pat Basu, Founder/Chairman Richard J Stephenson, CFO Douglas Costa, CIO Jennifer Greenman, CMO Julian Schink, COO Pete Govorchin, and CMO Ken Chaplin.

Cancer Treatment Centers of America firmographics

Firmographics
Name
Cancer Treatment Centers of America
Legal name
Cancer Treatment Centers of America
Website
https://cancercenter.com
Company type
Private
Founded year
1988
Operating status
Operating
Headcount range
5,001–10,000 employees
Short description
Cancer Treatment Centers of America, now operating as City of Hope, is a private national oncology platform running five hospital campuses and seven outpatient centers across the U.S., delivering comprehensive personalized cancer treatment to individual patients across 100+ cancer types.
Ownership category
akta.pro rank

Cancer Treatment Centers of America industry classification

Industry
Product category
Oncology Care Services
NAICS
Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Specialty (except Psychiatric and Substance Abuse) Hospitals (6223), Offices of Physicians (62111), Ambulatory Health Care Services (621)
SIC
Services-Hospitals (8060), Services-Specialty Outpatient Facilities, Nec (8093), Services-Offices & Clinics Of Doctors Of Medicine (8011)
akta.pro primary industry
Oncology & Cancer Specialty Hospitals (HLAFAHAC)
akta.pro secondary industries
Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI), Medical Oncology (HLAKAFAB), Oncology Remote Symptom Monitoring & Care Navigation (HLALAFAD)

Keywords

  • Cancer treatment services
  • Oncology care
  • Radiation therapy
  • Surgical oncology
  • Precision medicine

Where Cancer Treatment Centers of America is headquartered

Location

Headquarters

HQ city
Boca Raton
HQ country
United States
HQ region
North America

Offices12 records

Markets served

Cancer Treatment Centers of America business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

  1. Patient Care Services: Revenue generated from comprehensive cancer treatment services including inpatient hospital care, outpatient treatments, diagnostic procedures, surgical services, radiation therapy, chemotherapy, immunotherapy, and supportive care services at hospital campuses and outpatient care centers across multiple U.S. locations

Pricing tiers

ModelBillingPrice
OtherOtherQuote-based pricing - patient responsibility varies by insurance plan and treatment regimen

Go-to-market motion1 record

Distribution channels5 records

Marketing channels7 records

Cancer Treatment Centers of America product offering

Product offering

Core offering

Cancer Treatment Centers of America (CTCA), now operating under the City of Hope brand, provides comprehensive cancer diagnosis, treatment, and supportive care through a network of specialized cancer hospitals and outpatient care centers. Services span chemotherapy, radiation therapy, surgical oncology, immunotherapy, precision medicine, theranostics, diagnostic imaging, genetic and genomic testing, and supportive care, delivered by multidisciplinary teams under one roof.

Product overview

City of Hope (formerly Cancer Treatment Centers of America) is a unified cancer care platform comprising specialized cancer hospitals in Atlanta, Chicago, Duarte, Orange County, and Phoenix, supported by multiple Outpatient Care Centers. The organization offers a comprehensive suite of treatment modalities organized around dedicated cancer centers (Breast Cancer Center, GI Cancer Center, Lung Cancer Center) and treatment options including Chemotherapy, Radiation Therapy (external beam, internal, systemic), Surgical Oncology (including robotic surgery and ASURE recovery program), Immunotherapy (checkpoint inhibitors, CAR T-cell, vaccines), Precision Medicine, and Theranostics. Diagnostic capabilities span Genetic/Genomic Testing, Laboratory Tests (MammaPrint, Oncotype DX, CTC tests), and Imaging Services. Supportive Care Services include nutritional support, oncology rehabilitation, pain management, behavioral health, and survivorship support, all delivered through a multidisciplinary team approach under one roof.

Differentiator

Problem solved

Functional benefit

Brands

  • City of Hope Cancer Treatment Centers: Cancer treatment hospitals and outpatient care centers
  • Breast Cancer Center
  • GI Cancer Center
  • Lung Cancer Center

Products and services

  • City of Hope Cancer Treatment Hospitals A network of specialized cancer hospitals providing comprehensive inpatient and outpatient cancer care across multiple U.S. locations (Atlanta, Chicago, Duarte, Orange County, Phoenix). Targeted at adult cancer patients requiring multidisciplinary treatment.
  • Comprehensive Cancer Treatment Options Full spectrum of cancer treatment modalities including chemotherapy, radiation therapy, surgery, immunotherapy, targeted therapy, precision medicine, interventional oncology, and supportive care procedures for adult cancer patients.
  • Immunotherapy Program Cancer immunotherapy treatments including checkpoint inhibitors (PD-1, CTLA-4), CAR T-cell therapy, cancer vaccines, cytokines, and oncolytic virus therapy for adult cancer patients.
  • Chemotherapy Services Systemic chemotherapy treatments using alkylating agents, antimetabolites, antitumor antibiotics, topoisomerase inhibitors, mitotic inhibitors, and plant alkaloids, delivered in inpatient and outpatient settings.
  • Radiation Therapy Radiation oncology services including external beam radiation therapy (IMRT, IGRT, TomoTherapy, proton therapy, SRS, SBRT), internal radiation therapy (brachytherapy), and systemic radiation therapy for adult cancer patients.
  • Surgical Oncology Surgical cancer treatments including open surgery, minimally invasive laparoscopy, laser surgery, cryosurgery, robotic-assisted surgery, and reconstructive surgery for adult cancer patients.
  • Breast Cancer Center Dedicated breast cancer treatment center offering diagnosis, staging, and treatment for all breast cancer types including early-stage, triple-negative, and inflammatory breast cancer. Located within each City of Hope hospital campus.
  • GI Cancer Center Gastrointestinal cancer center specializing in colorectal cancer and other GI malignancies, with nutrition therapy and supportive care services. Located within each City of Hope hospital campus.
  • Lung Cancer Center Dedicated lung cancer center offering diagnosis, staging, and treatment for NSCLC and SCLC with advanced genomic testing and immunotherapy options. Located within each City of Hope hospital campus.
  • Prostate Cancer Treatment Prostate cancer treatment including 4D radiation therapy, hormone therapy, immunotherapy, and supportive care focused on quality-of-life maintenance for men diagnosed with prostate cancer.
  • Precision Medicine Personalized cancer treatment using genetic and tumor marker testing to design targeted therapies based on individual tumor signatures.
  • Advanced Surgical Recovery Program (ASURE) Enhanced recovery program combining pre-habilitation, nutrition, pain management with non-narcotic relievers, and physical activity within 24 hours post-surgery, for adult surgical oncology patients.
  • Diagnostic Services Comprehensive cancer diagnostics including biopsy, imaging (CT, MRI, PET/CT, mammography, ultrasound, X-ray, nuclear medicine), laboratory tests, and genetic/genomic testing for adult patients.
  • Genetic and Genomic Testing Advanced genomic testing of tumor DNA and genetic testing for inherited mutations (BRCA1/2) to identify treatment options and cancer risk for adult patients.
  • Laboratory Tests Clinical laboratory testing including CellSearch circulating tumor cell tests, CBC tests, flow cytometry, MammaPrint/BluePrint, Oncotype DX, CEA, and tumor marker tests for adult patients.
  • Supportive Care Services Whole-person supportive care including nutritional support, oncology rehabilitation, pain management, spiritual support, behavioral health, naturopathic support, and survivorship support for adult cancer patients and their families.
  • Theranostics Cancer care combining diagnostics and treatment, including radioactive iodine therapy and Pluvicto for targeted cancer treatment in adult patients.
  • Clinical Trials Access to clinical trials evaluating new drug development, technologies, and innovative treatment approaches for eligible adult cancer patients at City of Hope / CTCA facilities.
  • Outpatient Care Centers Multiple outpatient care centers in Downtown Chicago, Gilbert, North Phoenix, North Shore, Paces Ferry, Prescott, and Scottsdale providing consultations, follow-up care, and outpatient treatments closer to patients' homes.
  • Patient Portal Online patient portal for accessing medical records, scheduling, and communicating with the care team, available to City of Hope / CTCA patients.

Quantifiable outcome

  • Five-year survival rate of 65% for colorectal cancer when detected early (before spread), increasing to 91% when detected before metastasis
  • +2 more outcomes

Companies that use Cancer Treatment Centers of America

Customer profile

Named customers6 records

Segments6 records

Ideal customer profiles6 records

Cancer Treatment Centers of America technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature8 records

Cancer Treatment Centers of America partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves7 records

Expansion highlights5 records

Cancer Treatment Centers of America competitors and assessment

Company assessment

Direct peers

  • MD Anderson Cancer Center: One of the world's largest dedicated cancer centers, providing comprehensive inpatient and outpatient oncology care, research, and clinical trials. Directly comparable as a specialty oncology hospital network with multidisciplinary, research-driven cancer care.
  • Memorial Sloan Kettering Cancer Center: Premier specialty cancer hospital and research institution with multiple regional outpatient sites. Closely comparable to City of Hope/CTCA as a top-tier, research-driven oncology provider offering surgery, chemotherapy, radiation, immunotherapy, and precision medicine.
  • Dana-Farber Cancer Institute: Specialty cancer hospital and research center with multidisciplinary oncology care and clinical trials. Directly comparable as a research-intensive, specialty cancer provider with similar mission and care model.
  • Moffitt Cancer Center: NCI-designated Comprehensive Cancer Center offering inpatient and outpatient oncology services, research, and clinical trials. Comparable as a specialty cancer hospital network with multidisciplinary, research-driven cancer care.
  • Fred Hutchinson Cancer Center: Research-driven specialty cancer center with clinical care, bone marrow transplantation, and immunotherapy programs. Directly comparable as a research-intensive oncology specialty provider.

Broad incumbents

  • Mayo Clinic: Large, multispecialty academic health system with a major oncology program across multiple campuses. Comparable as a destination cancer care provider with research, complex care, and multidisciplinary teams, though oncology is part of a broader portfolio.
  • Cleveland Clinic: Multispecialty health system with a strong cancer institute and multiple regional hospitals. Comparable as a brand-led, geographically distributed provider of complex oncology care within a broader clinical portfolio.
  • HCA Healthcare: Largest for-profit hospital operator in the U.S., with significant oncology service lines across a national footprint. Comparable as a multi-state, for-profit provider of complex inpatient and outpatient cancer care, though within a diversified hospital portfolio.
  • Tenet Healthcare: For-profit hospital system operating specialty and acute care hospitals with oncology service lines. Comparable as a multi-state for-profit provider of complex inpatient and outpatient cancer care within a diversified portfolio.

Emerging players

  • U.S. Oncology Network (McKesson): Large network of community-based oncology practices affiliated through McKesson, providing medical oncology, infusion, and radiation services. Comparable as a multi-site oncology delivery platform, though community-focused rather than hospital-based.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Cancer Treatment Centers of America social profiles

Digital presence

Cancer Treatment Centers of America financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Cancer Treatment Centers of America leadership team

Management profile

Number of profiles

Profiles15 records

Cancer Treatment Centers of America funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Cancer Treatment Centers of America M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cancer Treatment Centers of America

What does Cancer Treatment Centers of America do?

Cancer Treatment Centers of America (CTCA), now operating under the City of Hope brand, provides comprehensive cancer diagnosis, treatment, and supportive care through a network of specialized cancer hospitals and outpatient care centers. Services span chemotherapy, radiation therapy, surgical oncology, immunotherapy, precision medicine, theranostics, diagnostic imaging, genetic and genomic testing, and supportive care, delivered by multidisciplinary teams under one roof.

Is Cancer Treatment Centers of America a public or private company?

Cancer Treatment Centers of America is a private company. It is classified as corporate owned and is currently operating.

When was Cancer Treatment Centers of America founded?

Cancer Treatment Centers of America was founded in 1988. It employs 5,001 to 10,000 people.

Where is Cancer Treatment Centers of America based?

Cancer Treatment Centers of America is headquartered in Boca Raton, United States, in the North America region.

How does Cancer Treatment Centers of America make money?

One revenue line is on record: patient Care Services.

Who are Cancer Treatment Centers of America's main competitors?

Direct peers on record are MD Anderson Cancer Center, Memorial Sloan Kettering Cancer Center, Dana-Farber Cancer Institute, Moffitt Cancer Center and Fred Hutchinson Cancer Center. Broad incumbents are Mayo Clinic, Cleveland Clinic, HCA Healthcare and Tenet Healthcare. U.S. Oncology Network (McKesson) is listed as an emerging player.

Does Cancer Treatment Centers of America have an API?

No public API is recorded for Cancer Treatment Centers of America.

What industry is Cancer Treatment Centers of America in?

Cancer Treatment Centers of America's product category is Oncology Care Services. Its primary akta.pro industry code is HLAFAHAC, Oncology & Cancer Specialty Hospitals, with a secondary code of HLAFABAI, Ambulatory Oncology Centers (Outpatient Chemo/Radiation). Its NAICS code is 622310 and its SIC code is 8060.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
AxiosCity of Hope buys Cancer Treatment Centers of America for $390 millionCity of Hope, a California cancer research nonprofit, acquired Cancer Treatment Centers of America for $390 million. The deal combines CTCA's hospitals and outpatient centers, which City of Hope plans to convert to not-for-profit status. The acquisition aims to expand its research hub with a broader patient base.PR NewswireCancerNetwork® Launches Its Strategic Alliance Partnership With Four Leading Cancer OrganizationsCancerNetwork® announced the launch of its Strategic Alliance Partnership with four cancer organizations as its inaugural class: the American Society for Transplantation and Cellular Therapy, American Oncology Network, the Association of Community Cancer Centers, and Cancer Treatment Centers of America. The partnerships are designed to help CancerNetwork® serve the multidisciplinary audience of oncology professionals across several specialties, expanding its reach to over 7.6 million physicians, pharmacists, and health care decision makers. MJH Life Sciences™, the parent company of CancerNetwork®, frames this as part of its commitment to the oncology community.PR NewswireCancer Treatment Centers of America CEO: "Delayed Cancer Care Will Cost More and More Lives" During Second Wave of COVID-19Cancer Treatment Centers of America CEO Pat Basu is warning that the COVID-19 second wave is causing significant delays in cancer care, creating a "shadow curve" of undiagnosed and untreated cancer patients. A recent study indicates that delaying cancer treatment by even one month increases patient mortality risk by 6% to 13%, with nearly 1.8 million cancer cases diagnosed annually yet screening appointments having declined substantially over the past eight months. The company is calling for cancer care to be treated as urgent and non-elective, warning that postponement of screenings, diagnostics, and clinical trial participation will cost lives.PR NewswireSolidarity HealthShare and Cancer Treatment Centers of America (CTCA) Announce Partnership to Offer Cost-Effective Cancer CareSolidarity HealthShare (SHS), a non-profit healthcare sharing ministry, has partnered with Cancer Treatment Centers of America (CTCA) to provide its members access to CTCA's oncology services at reduced costs. Under the agreement, CTCA becomes a preferred oncology provider for SHS, offering members direct access to CTCA's integrated cancer care model including surgery, radiation, chemotherapy, immunotherapy, and supportive therapies. The partnership aims to expand healthcare options for SHS members while decreasing medical expenses through negotiated rates.PR NewswireThe Association for Value-Based Cancer Care Launches Part Two of Webinar Series: COVID-19 Impact on the Cancer Care Delivery EcosystemThe Association for Value-Based Cancer Care (AVBCC) announced the launch of part two of its free webinar series focusing on COVID-19's impact on the cancer care delivery ecosystem, with the first segment debuting on July 14, 2020. The series, titled 'COVID-19 Impact on the Cancer Care Delivery Ecosystem: Recovery, The Road Ahead,' will feature speakers from Cancer Treatment Centers of America, Incyte Corporation, Integra Connect, Boston University School of Medicine, University of Florida College Pharmacy, and Mayo Clinic covering topics including IVIG, vaccines, oncology pharmacy, telehealth, and managed care updates. AVBCC founder Burt Zweigenhaft stated that the second series was developed to share lessons learned from the pandemic and help the oncology community move toward recovery.PR NewswireCancer Treatment Centers of America CEO Warns of Impending 'Shadow Curve' as Cancer Screenings and Treatments Plunge Amid PandemicCancer Treatment Centers of America (CTCA) President and CEO Pat Basu warned on May 21, 2020, of an impending cancer "shadow curve" resulting from a 37% drop in cancer diagnoses in the US compared to the prior year, as COVID-19 disrupted screenings and treatments. The company reported that approximately 1.8 million cancer cases are diagnosed annually, and many patients have skipped appointments over three months, risking worse outcomes if conditions go undetected. CTCA announced it has remained operational during the pandemic and introduced three virtual tools—an online cancer risk assessment, an Alexa skill, and a COVID-19 cancer chatbot—to help patients evaluate their risk and access care.PR NewswireVan Crocker, Jr., MBA, Joins Cancer Treatment Centers of America's Newly Formed Oncology Data, Analytics & Research Business as President and Co-FounderCancer Treatment Centers of America (CTCA) announced the appointment of Percy Van Crocker, Jr. as President and Co-Founder of its newly formed Oncology Data, Analytics & Research Business, effective April 6, 2020. Crocker, who previously led Healthagen at Aetna/CVS, will oversee a team dedicated to leveraging genomic and clinical data to improve patient outcomes and understand the patient journey. The announcement reflects CTCA's strategic push to expand its data analytics capabilities as a national oncology network.PR NewswireHealth, Hope & Inspiration Shares Special Podcasts to Allay Coronavirus Fears for Cancer Patients and FamiliesHealth, Hope & Inspiration, a podcast sponsored by Cancer Treatment Centers of America (CTCA), released a special series of episodes to address coronavirus fears among cancer patients and their families. The initial segment featured CTCA physicians providing medical guidance on the virus, while subsequent episodes focused on faith-based resources to alleviate anxiety.PR NewswireCancer Treatment Centers of America to Help Ease Pressure on Community Hospitals In Wake of COVID-19Cancer Treatment Centers of America (CTCA) announced on March 19, 2020, that it is offering to support cancer patients from neighboring acute care hospitals to help ease the strain on community hospitals overwhelmed by COVID-19 cases. President and CEO Dr. Pat Basu is calling on specialty cancer centers to become more proactive, citing the heightened risk immunocompromised cancer patients face from coronavirus exposure. CTCA has committed to accepting patients within safe driving distance of its facilities, implementing telehealth services, and working with other hospitals on ICU overflow and surgical needs.PR NewswireCancer Treatment Centers of America Hospitals Named to List of 22 Top Patient-Recommended Hospitals in the USCancer Treatment Centers of America (CTCA) announced that its hospitals in Chicago, Philadelphia, and Tulsa were named to Becker's Hospital Review's list of 22 'Top Patient-Recommended Hospitals' in the nation, based on HCAHPS scores from April 2018 through March 2019. At least 93 percent of patients at these facilities responded that they would definitely recommend the hospital to others. The recognition follows CTCA's seventh annual summary of Patient Treatment Results covering 11 tumor types.